Tilray Brands Inc

Tilray Brands surges as cannabis moves to Schedule III, launching Tilray Medical USA to tap a growing U.S. medical market—investors eye a new growth wave.

Tilray Brands Inc. reported a record $210 million in Q1 fiscal 2026 revenue and turned a profit of $1.5 million, marking a significant turnaround for the company.